# Team B — standalone batch 84 checkpoint — 2026-11-06

Repository: https://github.com/PortalHunter/Ethnicy-Based-Optimal-Weight/pull/71. Branch: research/atlas-team-b-20261104 → main. Checked draft/open/unmerged. RESEARCH INCOMPLETE; ZERO approved clinical claims; all Team B data only.

## Immutable research receipt and quantified progress

Data commit: https://github.com/PortalHunter/Ethnicy-Based-Optimal-Weight/commit/e20897f8b2d19dab43a44fe9c5aea0bd9a6d36ff.
493 nongovernmental organization records in 227/248 locally domiciled M49 areas (21 gaps); 381/1,736 raw source-positive area-condition cells (21.95%), 173/1,736 searched-unlinked (9.97%), 1,182/1,736 untouched (68.09%), 1,355 without a linked source; 417 exact contexts (all research_lead_only), 1,125 provenance and 648 search records. All 10 community/subnational, 8 cross-border and 14 ancestry-overgeneralization counterexamples retained. 5 original issuer-country imprints unresolved; zero approved clinical claims.

Batch 83 → 84: +1 organization (492→493), +0 local M49 domiciles (227→227), +2 source-positive cells (379→381), −1 searched-unlinked cell (174→173), −1 untouched cell (1,183→1,182), +2 publication/context pairs (415→417), +4 provenance (1,121→1,125), +3 search logs (645→648), +0 issuer-country resolutions (5 unresolved).

## Labeled progress bar graphs

```text
Geographic identity reach [██████████████████··] 227/248 (91.53%) | gaps 21 | delta 0
Condition-area raw reach  [████░░··············] source-positive 381/1736 (21.95%) | searched-unlinked 173/1736 (9.97%) | untouched 1182/1736 (68.09%) | delta positive +2
Legend: █ raw source-positive research lead; ░ searched without eligible link; · untouched (20-cell bars approximate proportional counts).
By condition positives out of 248 each: diabetes 110, hypertension 75, high_chol 48, gout 41, lactose 33, celiac 50, hemochromatosis 24.
```

## Exact sources and scientific/legal caveats

- Indonesia 360, B-ID-YGI: independent Jakarta-based gastroenterology educational foundation, founded 31 Aug 2018 according to its own site (https://ygi.or.id/tentang-ygi/). Independence and legal registration not independently audited; not a health regulator or PB PGI.
- Indonesia 360 lactose: 2019 first-party Indonesian-language original explanatory article https://ygi.or.id/apakah-itu-intoleransi-laktosa-dan-sama-kah-dengan-alergi-susu/ differentiates lactose intolerance from milk-protein allergy; S2 substantive education, not named original medical study, clinical guideline, ancestry or national prevalence finding. Newly source-positive from untouched.
- Indonesia 360 celiac: 2026-11-06 YGI original patient education https://ygi.or.id/mengenal-penyakit-celiac-ketika-tubuh-tidak-dapat-menoleransi-gluten/ names dr. Rabbinu Rangga Pribadi (RSCM/University of Indonesia) as author. S2 first-party educational content, not a PB PGI guideline, Indonesian national original cohort or validated diagnosis. Converted previous PGI-index D1 bounded cell to positive; old search retained.
- India 356 lactose: second independent route https://www.indianpediatrics.net/apr2020/apr-343-348.htm: original 2020 Indian Pediatrics journal discussion of therapeutic formulas and lactose, separate from previously checked ISG Master Class catalogue. D2 evidence-limited after two independent routes, still not eligible original ISG-issued resource; do not inflate raw positive or assert national absence. Separate Team C primary journal remit.
- Indonesia 360 gout: original Indonesian Rheumatologist Association panel recommendation abstract https://journalrheumatology.or.id/index.php/IJR/article/view/Management-of-Hyperuricemia-and-Gouty-Arthritis received provisional S1 audit. Publication page says online Feb 2026 in 2025 issue; separate 2024 society book not equivalent; full methodology, rights and clinical adoption not reviewed.
- Peru 604 gout historical 2025 course schedule https://socreuma.org.pe/new/_recursos/eventos/archivos/202506201252189886.pdf remains provisional M metadata-only, NOT a qualified S1/S2/H resource or demonstrated delivered lecture. Preserve source/provenance before any structural correction.

## Individual quality and search-depth review

Supplemental quality audit ledger: 4 individually classified source records out of 417 contexts (S1=1 provisional abstract, S2=2 educational pages, H=0, M=1 scheduled programme, U=0); 413 contexts not individually quality audited. Search-depth ledger has 4 historical rows (D1=3, D2=1, D3=0). India lactose D1 superseded by D2; Indonesia celiac D1 superseded by the positive YGI link; Egypt gout remains active D1. Depth of the majority of 173 unlinked cells remains unaudited and cannot be called D2-complete.

## Structural validation and readback

Immutable research data commit e20897f8b2d19dab43a44fe9c5aea0bd9a6d36ff (parent b3a50949fcbbf17010eb314a89c4892c6bfd5c25), full Git tree 95997b861cadb8eb9ec508cdfad52d038300b728, 154 entries nontruncated. All 10 canonical CSVs, unchanged validate.mjs and supplemental quality CSV independently refetched at immutable SHA and matched exact tree blob SHAs: 12/12. Independent JavaScript CSV widths, exact source/context/role/provenance and search joins, 248×7 roster, issuer enums, all research_lead_only, community/cross-border preservation and new audit ledger: zero structural errors. Actual Node CLI NOT RUN (direct GitHub git checkout DNS failed, no executable reconstruction completed). Combined commit status returned zero statuses; do not claim CI success or failure. No legal, copyright, clinical, fulltext or live-link approval.

## Remaining work, full restart protocol and scope

Still open: 1,182 untouched condition-area cells, especially haemochromatosis, lactose, gout and coeliac; 173 searched-unlinked cells with substantial D1/unknown-depth debt; 21 M49 local organization identity gaps; five unresolved original issuer-country imprints (Panama HEARTS, Portuguese WGO lactose translation, Portuguese ESPGHAN celiac translation, Chad OA Pub/JHC, South Sudan PAMJ). Peru original gout educational content versus scheduled programme; Egypt gout independent second search; society vs original authors and journal/host, rights, edition, clinical methods, Indigenous governance and consent remain unverified. No ancestry-to-individual-health inference. Team A government, Team C journals, Team D international networks, issue #27 clinical approval separate.

On restart read RUNBOOK.md, QUEUE.md, QUALITY_AND_COMPLETION.md, CONTINUE.md, CHECKPOINT.json, GAPS.md, VALIDATION.md, all 10 core CSVs, supplemental research_quality_audit.csv and unchanged validate.mjs. Requery PR head and changed paths, check CI/reviews, read exact source/cell IDs and original acceptance criteria. Research original-language nongovernmental sources and original attribution, without forced national absence or clinical claims. Only commit under docs/atlas/handoffs/team-b/. Never force-push or overwrite concurrent head. Recompute all metrics, run actual Node if possible or state exact limitations, read back immutable Git tree. Preserve previous historical checkpoints, 14 diversity counterexamples and community governance. PR must remain draft/open/unmerged.

## Exact reusable continuation prompt

Continue Research Team B in https://github.com/PortalHunter/Ethnicy-Based-Optimal-Weight/pull/71. On branch `research/atlas-team-b-20261104`, read `docs/atlas/handoffs/team-b/RUNBOOK.md`, `QUEUE.md`, and the latest `CONTINUE.md`. Follow the queue and safeguards; research, commit, validate, read back, and checkpoint Team B-only changes. Keep PR #71 draft/unmerged; approve no clinical claims. End with quantified run deltas, remaining gaps, and the required labeled progress bar graphs. Repeat this prompt.
